Drug Type Recombinant protein |
Synonyms |
Target |
Action agonists |
Mechanism TLR5 agonists(Toll like receptor 5 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alopecia | Preclinical | South Korea | 12 May 2023 | |
| Idiopathic Pulmonary Fibrosis | Preclinical | South Korea | 12 May 2023 | |
| Inflammation | Preclinical | South Korea | 12 May 2023 | |
| Nonalcoholic Steatohepatitis | Preclinical | South Korea | 12 May 2023 |






